Hans Wadenvik
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
MicroRNAs as potential architects of immune dysregulation and megakaryocytic failure in immune thrombocytopenia.
Journal: British journal of haematology
Published: January 21, 2026
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.
Journal: American journal of hematology
Published: January 06, 2022
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.
Journal: British journal of haematology
Published: November 30, 2020
Erratum to: Good adherence to imatinib therapy among patients with chronic myeloid leukemia-a single-center observational study.
Journal: Annals of hematology
Published: June 10, 2017
No increased prevalence of malignancies among first-degree relatives of 800 patients with chronic myeloid leukemia: a population-based study in Sweden.
Journal: Leukemia
Published: May 03, 2017
A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice.
Journal: European journal of haematology
Published: August 24, 2016
Advanced phase chronic myeloid leukaemia (CML) in the tyrosine kinase inhibitor era - a report from the Swedish CML register.
Journal: European journal of haematology
Published: July 07, 2016
Normalised immune expression in remission of paediatric ITP.
Journal: Thrombosis and haemostasis
Published: December 21, 2015
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Journal: British journal of haematology
Published: November 13, 2014
Last Updated: 09/26/2026